ABSTRACT

Women with isolated adenocarcinomas of axillary lymph node are a specific entity among carcinoma of unknown primary site (CUP), with a relatively good prognosis that decreases with the number of positive lymph nodes. The optimal therapeutic approaches are limited by the small number of data. The breast magnetic resonance imaging (MRI) should play an important role in the management of the local breast treatment. Recommendations of the systemic treatment (chemotherapy and/or hormonotherapy) should be the same as the treatment of breast cancer with axillary node involvement.